Your browser doesn't support javascript.
loading
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
Samadder, N Jewel; Foster, Nathan; McMurray, Ryan P; Burke, Carol A; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Vilar, E; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della'Zanna, Gary; Rodriguez, Luz M; Szabo, Eva; Zahrieh, David; Limburg, Paul J.
Afiliação
  • Samadder NJ; Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester, Minnesota, USA Samadder.Jewel@mayo.edu limburg.paul@mayo.edu.
  • Foster N; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • McMurray RP; Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester, Minnesota, USA.
  • Burke CA; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Stoffel E; Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Kanth P; Gastroenterology & Hepatology, University of Utah, Salt Lake City, Utah, USA.
  • Das R; Department of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Cruz-Correa M; Medicine, University of Puerto Rico, San Juan, Puerto Rico.
  • Vilar E; Cancer Biology, UPR Comprehensive Cancer Center, San Juan, Puerto Rico.
  • Mankaney G; Clinical Cancer Prevention, UT MD Anderson Cancer Center, Houston, Texas, USA.
  • Buttar N; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.
  • Thirumurthi S; Gastroenterology, Mayo Clinic, Rochester, Minnesota, Rochester, Minnesota, USA.
  • Turgeon DK; Gastroenterology, Hepatology and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
  • Sossenheimer M; Medicine/Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.
  • Westover M; Gastroenterology & Hepatology, University of Utah, Salt Lake City, Utah, USA.
  • Richmond E; Gastroenterology & Hepatology, University of Utah, Salt Lake City, Utah, USA.
  • Umar A; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Della'Zanna G; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Rodriguez LM; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Szabo E; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Zahrieh D; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Limburg PJ; Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester, Minnesota, USA.
Gut ; 72(2): 256-263, 2023 02.
Article em En | MEDLINE | ID: mdl-35636921
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Polipose Adenomatosa do Colo / Neoplasias Duodenais Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Polipose Adenomatosa do Colo / Neoplasias Duodenais Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article